# OnCo record lantern-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/lantern-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "lantern-pharma" ;
  schema:name "Lantern Pharma"@en ;
  schema:alternateName "Lantern Pharma Inc."@en, "NASDAQ:LTRN"@en ;
  schema:description "Lantern Pharma is a Texas company that uses its RADR machine-learning platform to revive shelved cancer drugs; LP-184 is a DNA-damaging agent activated in tumours with DNA repair defects, including glioblastoma."@en ;
  schema:url <https://onco.cc/companies/lantern-pharma/>, <https://www.lanternpharma.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.lanternpharma.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "US" ;
  onco:drugs <https://onco.cc/drugs/lp-184/> .
